The down‐regulation of miR‐433 up‐regulates FXYD3 levels in HCC tissues, which leads to the aberrant activation of PI3K‐AKT signalling, contributing to the angiogenic process of HCC (Figure 8). Here, FXYD3 is linked to hepatocellular carcinoma.